Clinical Streptococcus pneumoniae isolates induce differing CXCL8 responses from human nasopharyngeal epithelial cells which are reduced by liposomes

BMC Microbiology

Volumn 16, Issue 1, 2016, Pages

  Baumgartner, Denja ^a   Aebi, Suzanne ^a   Grandgirard, Denis ^a   Leib, Stephen L ^a   Draeger, Annette ^b   Babiychuk, Eduard ^b   Hathaway, Lucy J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Capsule; CXCL8; Liposomes; Pneumolysin; Streptococcus pneumoniae

Indexed keywords

CHOLESTEROL; CYTOKINE; INTERLEUKIN 8; LIPOSOME; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; PNEUMOLYSIN; SPHINGOMYELIN; TOLL LIKE RECEPTOR 2; VIRULENCE FACTOR; BACTERIAL PROTEIN; IL8 PROTEIN, HUMAN; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MULTILOCUS SEQUENCE TYPING; NASOPHARYNX; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; BACTERIAL CAPSULE; CELL CULTURE; CELL LINE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MUTATION; PATHOGENICITY;

BACTERIAL CAPSULES; BACTERIAL PROTEINS; CELL LINE; CELLS, CULTURED; CHOLESTEROL; CYTOKINES; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-8; LIPOSOMES; MUTATION; NASOPHARYNX; SPHINGOMYELINS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 84978472467     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-016-0777-5     Document Type: Article

References (21)

1. Mitchell T, Dalziel C. The biology of pneumolysin. Subcell Biochem. 2014;80:145-60.
2. Gomez M, Prince A. Airway epithelial cell signaling in response to bacterial pathogens. Pediatr Pulmonol. 2008;43:11-9.
3. Kato A, Schleimer R. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr Opin Immunol. 2007;19:711-20.
4. Rastogi D, Ratner A, Prince A. Host-bacterial interactions in the initiation of inflammation. Paediatr Respir Rev. 2001;2:245-52.
5. Lee H-Y, Andalibi A, Webster P, Moon S-K, Teufert K, Kang S-H, Li J-D, Nagura M, Ganz T, Lim D. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis. 2004;4:12.
6. Lock R, Zhang Q, Berry A, Paton J. Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin. Microb Pathog. 1996;21:71-83.
7. Kirkham L, Jefferies J, Kerr A, Jing Y, Clarke S, Smith A, Mitchell T. Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin. J Clin Micro. 2006;44:151-9.
8. Henry B, Neill D, Becker K, Gore S, Bricio-Moreno L, Ziobro R, Edwards M, Mühlemann K, Steinmann J, Kleuser B, et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat Biotechnol. 2014;33:81-8.
9. Alhamdi Y, Neill D, Abrams S, Malak H, Yahya R, Barrett-Jolley R, Wang G, Kadioglu A, Toh C. Circulation pneumolysin is a potent inducer of cardiac injury during pneumococcal infection. PLoS Pathog. 2015;11:e1004836.
10. Bentley S, Aanensen D, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, Donohoe K, Harris D, Murphy L, Quail M, et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2006;2:e31.
11. Küng E, Coward W, Neill D, Malak H, Mühlemann K, Kadioglu A, Hilty M, Hathaway L. The pneumococcal polysaccharide capsule and pneumolysin differentially affect CXCL8 and IL-6 release from cells of the upper and lower respiratory tract. PLoS One. 2014;9(3):e92355.
12. Hathaway L, Brugger S, Morand B, Bangert M, Rotzetter J, Hauser C, Graber W, Gore S, Kadioglu A, Muhlemann K. Capsule type of Streptococcus pneumoniae determines growth phenotype. PLoS Pathog. 2012;8:e1002574.
13. Leib S, Leppert D, Clements J, Tauber M. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun. 2000;68:615-20.
14. Dogan S, Zhang Q, Pridmore A, Mitchell T, Finn A, Murdoch C. Pneumolysin-induced CXCL8 production by nasopharyngeal epithelial cells is dependent on calcium flux and MAPK activation via Toll-like receptor 4. Microbes Infect. 2011;13:65-75.
15. McNeela E, Burke A, Neill D, Baxter C, Fernandes V, Ferreira D, Smeaton S, El-Rachkidy R, McLoughlin R, Mori A, et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 2010;6:e1001191.
16. Marriott H, Gascoyne K, Gowda R, Geary I, Nicklin M, Iannelli F, Pozzi G, Mitchell T, Whyte M, Sabroe I, et al. Interleukin-1beta regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages. Infect Immun. 2012;80:1140-9.
17. Vos A, Dessing M, Lammers A, Porto A, FLORquin S, Boer O, Beer R, Terpstra S, Bootsma H, Hermans P, et al. The polysaccharide capsule of Streptococcus pneumoniae partially impedes MyD88-mediated immunity during pneumonia in mice. PLoS One. 2015;10(e0118181):e0118181.
18. Grandgirard D, Oberson K, Buhlmann A, Gaumann R, Leib S. Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis. Antimicrob Agents Chemother. 2010;54:1323-6.
19. Ahl J, Littorin N, Forsgren A, Odenholt I, Resman F, Riesbeck K. High incidence of septic shock caused by Streptococcus pneumoniae serotype 3 - a retrospective epidemiological study. BMC Infect Dis. 2013;13:492-8.
20. Burgos J, Lujan M, Larrosa M, Pedro-Botet M, Fontanals D, Quesada M, Lung M, Bermudo G, Almirante B, Falco V. The problem of early mortality in pneumococcal pneumonia: a study of risk factors. Eur Respir J. 2015;46:561-4.
21. Jefferies J, Johnston C, Kirkham L-A, Cowan G, Ross K, Smith A, Clarke S, Brueggemann A, George R, Pichon B, et al. Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis. 2007;196:936-44.